Pulmonary hypertension right heart catheterization: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(One intermediate revision by one other user not shown)
Line 12: Line 12:
*[[Fick’s method]] is reliable in patients with PAH for the measurement of cardiac output:
*[[Fick’s method]] is reliable in patients with PAH for the measurement of cardiac output:


<figure-inline>[[Image:Fick's principal for calculating cardiac output.png|600x600px]]</figure-inline>
[[Image:Fick's principal for calculating cardiac output.png|400x400px]]
   
   
*Since end-expiratory intrathoracic pressure most closely correlates with atmospheric pressure, it is important that all right ventricular, pulmonary artery, pulmonary wedge, and left ventricular pressures be measured at end-expiration.
*Since end-expiratory intrathoracic pressure most closely correlates with atmospheric pressure, it is important that all right ventricular, pulmonary artery, pulmonary wedge, and left ventricular pressures be measured at end-expiration.
Line 45: Line 45:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Medicine]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Disease]]
[[Category:Emergency medicine]]
[[Category:Mature chapter]]
[[Category:Up-To-Date]]
[[Category:Radiology]]

Latest revision as of 03:27, 5 May 2021

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension right heart catheterization On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension right heart catheterization

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension right heart catheterization

CDC on Pulmonary hypertension right heart catheterization

Pulmonary hypertension right heart catheterization in the news

Blogs on Pulmonary hypertension right heart catheterization

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension right heart catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-in-Chief: Ralph Matar; Rim Halaby

Overview

Cardiac catheterization is still the gold standard for diagnosing, assessing the severity, and determining the prognosis and response to therapy in pulmonary hypertension. In the cardiac catheterization laboratory, inhaled nitric oxide is administered to determine if the pulmonary vasculature is still reactive or if the obstruction is fixed. It is dangerous to give nifedipine IV as a test because it could lead to a dangerous episode of hypotension. This procedure has been shown to be safe, with no deaths reported in the NIH registry study. In addition, a recent study reported a procedure-related mortality of 0.055%.

Right Heart Catheterization

  • Since end-expiratory intrathoracic pressure most closely correlates with atmospheric pressure, it is important that all right ventricular, pulmonary artery, pulmonary wedge, and left ventricular pressures be measured at end-expiration.


<figure-inline><figure-inline></figure-inline></figure-inline> <figure-inline><figure-inline></figure-inline></figure-inline>

References

  1. Rosenkranz S, Preston IR (December 2015). "Right heart catheterisation: best practice and pitfalls in pulmonary hypertension". Eur Respir Rev. 24 (138): 642–52. doi:10.1183/16000617.0062-2015. PMID 26621978.
  2. Guo X, Liu M, Ma Z, Wang S, Yang Y, Zhai Z, Wang C, Zhai R (2014). "Flow characteristics of the proximal pulmonary arteries and vena cava in patients with chronic thromboembolic pulmonary hypertension: correlation between 3.0 T phase-contrast MRI and right heart catheterization". Diagn Interv Radiol. 20 (5): 414–20. doi:10.5152/dir.2014.13501. PMC 4463330. PMID 25163757.
  3. Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (August 2014). "Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population". J Am Heart Assoc. 3 (4). doi:10.1161/JAHA.114.001103. PMC 4310406. PMID 25146706.
  4. D'Alto M, Romeo E, Argiento P, D'Andrea A, Vanderpool R, Correra A, Bossone E, Sarubbi B, Calabrò R, Russo MG, Naeije R (October 2013). "Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension". Int. J. Cardiol. 168 (4): 4058–62. doi:10.1016/j.ijcard.2013.07.005. PMID 23890907.
  5. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ (December 2006). "Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers". J. Am. Coll. Cardiol. 48 (12): 2546–52. doi:10.1016/j.jacc.2006.07.061. PMID 17174196.
  6. Taylor B, Rumbak M, Taylor SP, Solomon D (January 2013). "Early versus delayed right heart catheterization in evaluation of pulmonary arterial hypertension". J. Heart Lung Transplant. 32 (1): 137–8. doi:10.1016/j.healun.2012.10.004. PMID 23260714.

Template:WikiDoc Sources